Improving Global Health

VTC Researcher in Bangladesh holding baby with motherFaculty researchers at the Vaccine Testing Center (VTC) study human vaccines with the goal of understanding and preventing infectious diseases around the globe. The VTC is in the Department of Microbiology and Molecular Genetics, which bridges both the University of Vermont College of Agriculture and Life Sciences and the Larner College of Medicine.

Our team is particularly interested in new vaccines with the potential to prevent or control infectious diseases in developing countries. We are a diverse team of clinicians, study coordinators, scientists, and laboratory personnel. Volunteers are critical to our work and our human research studies are designed and performed with rigorous oversight and safety.

Research 

Lab Tech looking in microscope

The Vaccine Testing Center's team of scientists and researchers are committed to solving the world’s most pressing infectious disease challenges. Our research spans the translational spectrum from lab-based human immunology to domestic clinical trials to large-scale international field research. Together with national and international collaborators and local volunteers, we help develop vaccines to address global infectious diseases, including rotavirus, cholera, dengue and other flaviviruses. More VTC research.

Volunteer

Join the Fight - Volunteer for a Vaccine Trial

When you volunteer for a vaccine testing study, you help researchers develop potentially lifesaving vaccines. Volunteers act locally to create global change.

Find out more about what it's like to volunteer for a vaccine study and check out our FAQs.

Interested in volunteering for a COVID-19 Vaccine Trial?

Visit the UVMMC COVID-19 vaccine trial webpage to learn more about the ongoing trial in VT.

TGIR COBRETranslational Global Infectious Disease Center, Cute Tiger Scientist

The Translational Global Infectious Disease Research Center (TGIR) Center of Biomedical Research Excellence (COBRE) is funded by the National Institutes of Health (NIH). This innovative center will leverage UVM's substantial existing strengths in global infectious diseases research, complex systems and computational modeling to develop creative, translational approaches to prevent and control infectious disease around the world.

To learn more visit the TGIR website.

 

VTC Researchers speak about COVID vaccines in the U.S.

Dr. Kristen Pierce was recently interviewed on our local WPTZ 5 station. Hear what our expert has to say about the COVID vaccines currently in national Phase lll trials.

Dr. Beth Kirkpatrick, VTC Director, spoke recently to WCAX about the development and goals of a COVID vaccine in the U.S. See the interview on WCAX. 

Dr. Sean Diehl was recently interviewed on WCAX about his lab's development of an accurate, inexpensive, open-source serology test that can be used for large-scale tracking of the Coronavirus. The team is hopeful that the test can be put to good use to help Vermont and other states research and monitor the spread of COVID-19 among their populations. 

Call to volunteer with woman wearing mask

VTC and UVM Health Network AZ COVID-19 Vaccine Trial Underway

The VTC and the UVM Health Network are now enrolling participants in the AZD1222 COVID-19 Vaccine Study to research a vaccine to prevent COVID-19. To learn more and do a pre-screen survey, visit UVMMC's COVID-19-vaccine-study web page.

Local WCAX continues it's coverage of this exciting effort and talks to two of the first volunteers. 

Dr. Huy Tu in lab smilingHuy Tu, Ph.D., successfully defended his doctoral dissertation, “Determinants of antibody immunity in flavivirus infections and immunization,” on September 22, 2020. His thesis explored the cellular underpinnings of how the immune response, particularly B cells, responds to and develops memory to infection or vaccination against the mosquito-borne viruses dengue and zika". Dr. Tu will continue as a Postdoctoral Associate in the Diehl lab.

Donations to the Vaccine Testing Center support groundbreaking research and clinical trials that improve people's quality of life and overall global health. More

Donate Button